<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37667413</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2051-817X</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>17</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Physiological reports</Title><ISOAbbreviation>Physiol Rep</ISOAbbreviation></Journal><ArticleTitle>Decreased plasma cartilage acidic protein 1 in COVID-19.</ArticleTitle><Pagination><StartPage>e15814</StartPage><MedlinePgn>e15814</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e15814</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.14814/phy2.15814</ELocationID><Abstract><AbstractText>Cartilage acidic protein-1 (CRTAC1) is produced by several cell types, including Type 2 alveolar epithelial (T2AE) cells that are targeted by SARS-CoV2. Plasma CRTAC1 is known based on proteomic surveys to be low in patients with severe COVID-19. Using an ELISA, we found that patients treated for COVID-19 in an ICU almost uniformly had plasma concentrations of CRTAC1 below those of healthy controls. Magnitude of decrease in CRTAC1 distinguished COVID-19 from other causes of acute respiratory decompensation and correlated with established metrics of COVID-19 severity. CRTAC1 concentrations below those of controls were found in some patients a year after hospitalization with COVID-19, long COVID after less severe COVID-19, or chronic obstructive pulmonary disease. Decreases in CRTAC1 in severe COVID-19 correlated (r&#x2009;=&#x2009;0.37, p&#x2009;=&#x2009;0.0001) with decreases in CFP (properdin), which interacts with CRTAC1. Thus, decreases of CRTAC1 associated with severe COVID-19 may result from loss of production by T2AE cells or co-depletion with CFP. Determination of significance of and reasons behind decreased CRTAC1 concentration in a subset of patients with long COVID will require analysis of roles of preexisting lung disease, impact of prior acute COVID-19, age, and other confounding variables in a larger number of patients.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Johansson</LastName><ForeName>Mats W</ForeName><Initials>MW</Initials><Identifier Source="ORCID">0000-0001-5699-978X</Identifier><AffiliationInfo><Affiliation>Morgridge Institute for Research, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balnis</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Albany Medical Center, Albany, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular and Cellular Physiology, Albany Medical College, Albany, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muehlbauer</LastName><ForeName>Laura K</ForeName><Initials>LK</Initials><AffiliationInfo><Affiliation>National Center for Quantitative Biology of Complex Systems, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bukhman</LastName><ForeName>Yury V</ForeName><Initials>YV</Initials><AffiliationInfo><Affiliation>Morgridge Institute for Research, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stefely</LastName><ForeName>Matthew S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Morgridge Institute for Research, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Overmyer</LastName><ForeName>Katherine A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Morgridge Institute for Research, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for Quantitative Biology of Complex Systems, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vancavage</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Albany Medical Center, Albany, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular and Cellular Physiology, Albany Medical College, Albany, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tiwari</LastName><ForeName>Anupama</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Albany Medical Center, Albany, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular and Cellular Physiology, Albany Medical College, Albany, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adhikari</LastName><ForeName>Anish Raj</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Albany Medical Center, Albany, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular and Cellular Physiology, Albany Medical College, Albany, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feustel</LastName><ForeName>Paul J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Bradford S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Morgridge Institute for Research, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coon</LastName><ForeName>Joshua J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Morgridge Institute for Research, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for Quantitative Biology of Complex Systems, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>Ron</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Morgridge Institute for Research, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaitovich</LastName><ForeName>Ariel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Albany Medical Center, Albany, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular and Cellular Physiology, Albany Medical College, Albany, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosher</LastName><ForeName>Deane F</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>Morgridge Institute for Research, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL160661</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG066179</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI173035</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P41 GM108538</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01 HL130704</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Physiol Rep</MedlineTA><NlmUniqueID>101607800</NlmUniqueID><ISSNLinking>2051-817X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002135">Calcium-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C422245">CRTAC1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002135" MajorTopicYN="Y">Calcium-Binding Proteins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CFP/properdin</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">CRTAC1</Keyword><Keyword MajorTopicYN="N">Type 2 alveolar epithelial cells</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>5</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>23</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37667413</ArticleId><ArticleId IdType="pmc">PMC10477339</ArticleId><ArticleId IdType="doi">10.14814/phy2.15814</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anjos, L. , Morgado, I. , Guerreiro, M. , Cardoso, J. C. , Melo, E. P. , &amp; Power, D. M. (2017). Cartilage acidic protein 1, a new member of the beta&#x2010;propeller protein family with amyloid propensity. Proteins, 85, 242&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">27862299</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballard, P. L. , Lee, J. W. , Fang, X. , Chapin, C. , Allen, L. , Segal, M. R. , Fischer, H. , Illek, B. , Gonzales, L. W. , Kolla, V. , &amp; Matthay, M. A. (2010). Regulated gene expression in cultured type II cells of adult human lung. American Journal of Physiology. Lung Cellular and Molecular Physiology, 299, L36&#x2013;L50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2904098</ArticleId><ArticleId IdType="pubmed">20382749</ArticleId></ArticleIdList></Reference><Reference><Citation>Balnis, J. , Madrid, A. , Hogan, K. J. , Drake, L. A. , Adhikari, A. , Vancavage, R. , Singer, H. A. , Alisch, R. S. , &amp; Jaitovich, A. (2022). Persistent blood DNA methylation changes one year after SARS&#x2010;CoV&#x2010;2 infection. Clinical Epigenetics, 14, 94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9308917</ArticleId><ArticleId IdType="pubmed">35871090</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini, Y. , &amp; Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful apporach to multiple testing. Journal of the Royal Statistical Society: Series B, 57, 289&#x2013;300.</Citation></Reference><Reference><Citation>Bland, J. M. , &amp; Altman, D. G. (1995). Multiple significance tests: The Bonferroni method. BMJ, 310, 170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2548561</ArticleId><ArticleId IdType="pubmed">7833759</ArticleId></ArticleIdList></Reference><Reference><Citation>Boussier, J. , Yatim, N. , Marchal, A. , Hadjadj, J. , Charbit, B. , El Sissy, C. , Carlier, N. , Pene, F. , Mouthon, L. , Tharaux, P. L. , Bergeron, A. , Smadja, D. M. , Rieux&#x2010;Laucat, F. , Duffy, D. , Kerneis, S. , Fremeaux&#x2010;Bacchi, V. , &amp; Terrier, B. (2022). Severe COVID&#x2010;19 is associated with hyperactivation of the alternative complement pathway. The Journal of Allergy and Clinical Immunology, 149, 550&#x2013;556.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8595971</ArticleId><ArticleId IdType="pubmed">34800432</ArticleId></ArticleIdList></Reference><Reference><Citation>Byeon, S. K. , Madugundu, A. K. , Garapati, K. , Ramarajan, M. G. , Saraswat, M. , Kumar, M. P. , Hughes, T. , Shah, R. , Patnaik, M. M. , Chia, N. , Ashrafzadeh&#x2010;Kian, S. , Yao, J. D. , Pritt, B. S. , Cattaneo, R. , Salama, M. E. , Zenka, R. M. , Kipp, B. R. , Grebe, S. K. G. , Singh, R. J. , &#x2026; Pandey, A. (2022). Development of a multiomics model for identification of predictive biomarkers for COVID&#x2010;19 severity: A retrospective cohort study. Lancet Digit Health, 4, e632&#x2013;e645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9273185</ArticleId><ArticleId IdType="pubmed">35835712</ArticleId></ArticleIdList></Reference><Reference><Citation>Chait, M. , Yilmaz, M. M. , Shakil, S. , Ku, A. W. , Dogra, P. , Connors, T. J. , Szabo, P. A. , Gray, J. I. , Wells, S. B. , Kubota, M. , Matsumoto, R. , Poon, M. M. , Snyder, M. E. , Baldwin, M. R. , Sims, P. A. , Saqi, A. , Farber, D. L. , &amp; Weisberg, S. P. (2022). Immune and epithelial determinants of age&#x2010;related risk and alveolar injury in fatal COVID&#x2010;19. JCI Insight, 7, e157608.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9228710</ArticleId><ArticleId IdType="pubmed">35446789</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox, J. , Hein, M. Y. , Luber, C. A. , Paron, I. , Nagaraj, N. , &amp; Mann, M. (2014). Accurate proteome&#x2010;wide label&#x2010;free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Molecular &amp; Cellular Proteomics, 13, 2513&#x2013;2526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4159666</ArticleId><ArticleId IdType="pubmed">24942700</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorey, T. M. , Ziegler, C. G. K. , Heimberg, G. , Normand, R. , Yang, Y. , Segerstolpe, A. , Abbondanza, D. , Fleming, S. J. , Subramanian, A. , Montoro, D. T. , Jagadeesh, K. A. , Dey, K. K. , Sen, P. , Slyper, M. , Pita&#x2010;Juarez, Y. H. , Phillips, D. , Biermann, J. , Bloom&#x2010;Ackermann, Z. , Barkas, N. , &#x2026; Regev, A. (2021). COVID&#x2010;19 tissue atlases reveal SARS&#x2010;CoV&#x2010;2 pathology and cellular targets. Nature, 595, 107&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8919505</ArticleId><ArticleId IdType="pubmed">33915569</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabay, C. , &amp; Kushner, I. (1999). Acute&#x2010;phase proteins and other systemic responses to inflammation. The New England Journal of Medicine, 340, 448&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pubmed">9971870</ArticleId></ArticleIdList></Reference><Reference><Citation>Geyer, P. E. , Kulak, N. A. , Pichler, G. , Holdt, L. M. , Teupser, D. , &amp; Mann, M. (2016). Plasma proteome profiling to assess human health and disease. Cell Systems, 2, 185&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pubmed">27135364</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, J. , Hume, A. J. , Abo, K. M. , Werder, R. B. , Villacorta&#x2010;Martin, C. , Alysandratos, K. D. , Beermann, M. L. , Simone&#x2010;Roach, C. , Lindstrom&#x2010;Vautrin, J. , Olejnik, J. , Suder, E. L. , Bullitt, E. , Hinds, A. , Sharma, A. , Bosmann, M. , Wang, R. , Hawkins, F. , Burks, E. J. , Saeed, M. , &#x2026; Kotton, D. N. (2020). SARS&#x2010;CoV&#x2010;2 infection of pluripotent stem cell&#x2010;derived human lung alveolar type 2 cells elicits a rapid epithelial&#x2010;intrinsic inflammatory response. Cell Stem Cell, 27, 962&#x2013;973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7500949</ArticleId><ArticleId IdType="pubmed">32979316</ArticleId></ArticleIdList></Reference><Reference><Citation>Huttlin, E. L. , Bruckner, R. J. , Navarrete&#x2010;Perea, J. , Cannon, J. R. , Baltier, K. , Gebreab, F. , Gygi, M. P. , Thornock, A. , Zarraga, G. , Tam, S. , Szpyt, J. , Gassaway, B. M. , Panov, A. , Parzen, H. , Fu, S. , Golbazi, A. , Maenpaa, E. , Stricker, K. , Guha Thakurta, S. , &#x2026; Gygi, S. P. (2021). Dual proteome&#x2010;scale networks reveal cell&#x2010;specific remodeling of the human interactome. Cell, 184, 3022&#x2013;3040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8165030</ArticleId><ArticleId IdType="pubmed">33961781</ArticleId></ArticleIdList></Reference><Reference><Citation>Izcovich, A. , Ragusa, M. A. , Tortosa, F. , Lavena Marzio, M. A. , Agnoletti, C. , Bengolea, A. , Ceirano, A. , Espinosa, F. , Saavedra, E. , Sanguine, V. , Tassara, A. , Cid, C. , Catalano, H. N. , Agarwal, A. , Foroutan, F. , &amp; Rada, G. (2020). Prognostic factors for severity and mortality in patients infected with COVID&#x2010;19: A systematic review. PLoS One, 15, e0241955.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7671522</ArticleId><ArticleId IdType="pubmed">33201896</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsura, H. , Sontake, V. , Tata, A. , Kobayashi, Y. , Edwards, C. E. , Heaton, B. E. , Konkimalla, A. , Asakura, T. , Mikami, Y. , Fritch, E. J. , Lee, P. J. , Heaton, N. S. , Boucher, R. C. , Randell, S. H. , Baric, R. S. , &amp; Tata, P. R. (2020). Human lung stem cell&#x2010;based Alveolospheres provide insights into SARS&#x2010;CoV&#x2010;2&#x2010;mediated interferon responses and pneumocyte dysfunction. Cell Stem Cell, 27, 890&#x2013;904.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577733</ArticleId><ArticleId IdType="pubmed">33128895</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami, Y. , Kurihara, Y. , Saito, Y. , Fujita, Y. , Yamashita, T. , &amp; Takei, K. (2018). The soluble form of LOTUS inhibits Nogo receptor&#x2010;mediated signaling by interfering with the interaction between Nogo receptor type 1 and p75 Neurotrophin receptor. The Journal of Neuroscience, 38, 2589&#x2013;2604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6705898</ArticleId><ArticleId IdType="pubmed">29440387</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurihara, Y. , Iketani, M. , Ito, H. , Nishiyama, K. , Sakakibara, Y. , Goshima, Y. , &amp; Takei, K. (2014). LOTUS suppresses axon growth inhibition by blocking interaction between Nogo receptor&#x2010;1 and all four types of its ligand. Molecular and Cellular Neurosciences, 61, 211&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pubmed">25034269</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayr, C. H. , Simon, L. M. , Leuschner, G. , Ansari, M. , Schniering, J. , Geyer, P. E. , Angelidis, I. , Strunz, M. , Singh, P. , Kneidinger, N. , Reichenberger, F. , Silbernagel, E. , Bohm, S. , Adler, H. , Lindner, M. , Maurer, B. , Hilgendorff, A. , Prasse, A. , Behr, J. , &#x2026; Schiller, H. B. (2021). Integrative analysis of cell state changes in lung fibrosis with peripheral protein biomarkers. EMBO Molecular Medicine, 13, e12871.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8033531</ArticleId><ArticleId IdType="pubmed">33650774</ArticleId></ArticleIdList></Reference><Reference><Citation>Melms, J. C. , Biermann, J. , Huang, H. , Wang, Y. , Nair, A. , Tagore, S. , Katsyv, I. , Rendeiro, A. F. , Amin, A. D. , Schapiro, D. , Frangieh, C. J. , Luoma, A. M. , Filliol, A. , Fang, Y. , Ravichandran, H. , Clausi, M. G. , Alba, G. A. , Rogava, M. , Chen, S. W. , &#x2026; Izar, B. (2021). A molecular single&#x2010;cell lung atlas of lethal COVID&#x2010;19. Nature, 595, 114&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8814825</ArticleId><ArticleId IdType="pubmed">33915568</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishida, R. , Kawaguchi, Y. , Matsubayashi, J. , Ishikawa, R. , Kida, S. , &amp; Takei, K. (2021). LOTUS, an endogenous Nogo receptor antagonist, is involved in synapse and memory formation. Scientific Reports, 11, 5085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7930056</ArticleId><ArticleId IdType="pubmed">33658590</ArticleId></ArticleIdList></Reference><Reference><Citation>Overmyer, K. A. , Shishkova, E. , Miller, I. J. , Balnis, J. , Bernstein, M. N. , Peters&#x2010;Clarke, T. M. , Meyer, J. G. , Quan, Q. , Muehlbauer, L. K. , Trujillo, E. A. , He, Y. , Chopra, A. , Chieng, H. C. , Tiwari, A. , Judson, M. A. , Paulson, B. , Brademan, D. R. , Zhu, Y. , Serrano, L. R. , &#x2026; Jaitovich, A. (2021). Large&#x2010;scale multi&#x2010;omic analysis of COVID&#x2010;19 severity. Cell Systems, 12, 23&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543711</ArticleId><ArticleId IdType="pubmed">33096026</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen, D. V. , Lorentzen, J. , &amp; Andersen, G. R. (2023). Structural studies offer a framework for understanding the role of properdin in the alternative pathway and beyond. Immunological Reviews, 313, 46&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10087229</ArticleId><ArticleId IdType="pubmed">36097870</ArticleId></ArticleIdList></Reference><Reference><Citation>Piktel, E. , Levental, I. , Durnas, B. , Janmey, P. A. , &amp; Bucki, R. (2018). Plasma gelsolin: Indicator of inflammation and its potential as a diagnostic tool and therapeutic target. International Journal of Molecular Sciences, 19, 2516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6164782</ArticleId><ArticleId IdType="pubmed">30149613</ArticleId></ArticleIdList></Reference><Reference><Citation>Porritt, R. A. , Binek, A. , Paschold, L. , Rivas, M. N. , McArdle, A. , Yonker, L. M. , Alter, G. , Chandnani, H. K. , Lopez, M. , Fasano, A. , Van Eyk, J. E. , Binder, M. , &amp; Arditi, M. (2021). The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children. The Journal of Clinical Investigation, 131, e151530.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8516454</ArticleId><ArticleId IdType="pubmed">34437303</ArticleId></ArticleIdList></Reference><Reference><Citation>Redruello, B. , Louro, B. , Anjos, L. , Silva, N. , Greenwell, R. S. , Canario, A. V. , &amp; Power, D. M. (2010). CRTAC1 homolog proteins are conserved from cyanobacteria to man and secreted by the teleost fish pituitary gland. Gene, 456, 1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">20171266</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez de Cordoba, S. (2023). Genetic variability shapes the alternative pathway complement activity and predisposition to complement&#x2010;related diseases. Immunological Reviews, 313, 71&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10086816</ArticleId><ArticleId IdType="pubmed">36089777</ArticleId></ArticleIdList></Reference><Reference><Citation>Sannes, P. L. (1984). Differences in basement membrane&#x2010;associated microdomains of type I and type II pneumocytes in the rat and rabbit lung. The Journal of Histochemistry and Cytochemistry, 32, 827&#x2013;833.</Citation><ArticleIdList><ArticleId IdType="pubmed">6747274</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato, Y. , Iketani, M. , Kurihara, Y. , Yamaguchi, M. , Yamashita, N. , Nakamura, F. , Arie, Y. , Kawasaki, T. , Hirata, T. , Abe, T. , Kiyonari, H. , Strittmatter, S. M. , Goshima, Y. , &amp; Takei, K. (2011). Cartilage acidic protein&#x2010;1B (LOTUS), an endogenous Nogo receptor antagonist for axon tract formation. Science, 333, 769&#x2013;773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3244695</ArticleId><ArticleId IdType="pubmed">21817055</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen, B. , Yi, X. , Sun, Y. , Bi, X. , Du, J. , Zhang, C. , Quan, S. , Zhang, F. , Sun, R. , Qian, L. , Ge, W. , Liu, W. , Liang, S. , Chen, H. , Zhang, Y. , Li, J. , Xu, J. , He, Z. , Chen, B. , &#x2026; Guo, T. (2020). Proteomic and metabolomic characterization of COVID&#x2010;19 patient sera. Cell, 182, 59&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7254001</ArticleId><ArticleId IdType="pubmed">32492406</ArticleId></ArticleIdList></Reference><Reference><Citation>Siggins, M. K. , Davies, K. , Fellows, R. , Thwaites, R. S. , Baillie, J. K. , Semple, M. G. , Openshaw, P. J. M. , Zelek, W. M. , Harris, C. L. , Morgan, B. P. , &amp; Investigators, I. C. (2023). Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID&#x2010;19. Immunology, 168, 473&#x2013;492.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9537932</ArticleId><ArticleId IdType="pubmed">36175370</ArticleId></ArticleIdList></Reference><Reference><Citation>Steck, E. , Benz, K. , Lorenz, H. , Loew, M. , Gress, T. , &amp; Richter, W. (2001). Chondrocyte expressed protein&#x2010;68 (CEP&#x2010;68), a novel human marker gene for cultured chondrocytes. The Biochemical Journal, 353, 169&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1221555</ArticleId><ArticleId IdType="pubmed">11139377</ArticleId></ArticleIdList></Reference><Reference><Citation>Steck, E. , Braun, J. , Pelttari, K. , Kadel, S. , Kalbacher, H. , &amp; Richter, W. (2007). Chondrocyte secreted CRTAC1: A glycosylated extracellular matrix molecule of human articular cartilage. Matrix Biology, 26, 30&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">17074475</ArticleId></ArticleIdList></Reference><Reference><Citation>Styrkarsdottir, U. , Lund, S. H. , Saevarsdottir, S. , Magnusson, M. I. , Gunnarsdottir, K. , Norddahl, G. L. , Frigge, M. L. , Ivarsdottir, E. V. , Bjornsdottir, G. , Holm, H. , Thorgeirsson, G. , Rafnar, T. , Jonsdottir, I. , Ingvarsson, T. , Jonsson, H. , Sulem, P. , Thorsteinsdottir, U. , Gudbjartsson, D. , &amp; Stefansson, K. (2021). The CRTAC1 protein in plasma associates with osteoarthritis and predicts progression to joint replacements: A large&#x2010;scale proteomics scan in Iceland. Arthritis &amp; Rhematology, 73, 2025&#x2013;2034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8596997</ArticleId><ArticleId IdType="pubmed">33982893</ArticleId></ArticleIdList></Reference><Reference><Citation>Styrkarsdottir, U. , Lund, S. H. , Thorleifsson, G. , Saevarsdottir, S. , Gudbjartsson, D. F. , Thorsteinsdottir, U. , &amp; Stefansson, K. (2023). Cartilage acidic protein 1 in plasma associates with prevalent osteoarthritis and predicts future risk as well as progression to joint replacements: Results from the UK biobank resource. Arthritis &amp; Rhematology, 75, 544&#x2013;552.</Citation><ArticleIdList><ArticleId IdType="pubmed">36239377</ArticleId></ArticleIdList></Reference><Reference><Citation>Szilagyi, I. A. , Vallerga, C. L. , Boer, C. G. , Schiphof, D. , Ikram, M. A. , Bierma&#x2010;Zeinstra, S. M. A. , &amp; van Meurs, J. B. J. (2023). Plasma proteomics identifies CRTAC1 as a biomarker for osteoarthritis severity and progression. Rheumatology, 62, 1286&#x2013;1295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9977119</ArticleId><ArticleId IdType="pubmed">35924962</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabula Sapiens Consortium , Jones, R. C. , Karkanias, J. , Krasnow, M. A. , Pisco, A. O. , Quake, S. R. , Salzman, J. , Yosef, N. , Bulthaup, B. , Brown, P. , Harper, W. , Hemenez, M. , Ponnusamy, R. , Salehi, A. , Sanagavarapu, B. A. , Spallino, E. , Aaron, K. A. , Concepcion, W. , &#x2026; Wyss&#x2010;Coray, T. (2022). The Tabula Sapiens: A multiple&#x2010;organ, single&#x2010;cell transcriptomic atlas of humans. Science, 376, eabl4896.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9812260</ArticleId><ArticleId IdType="pubmed">35549404</ArticleId></ArticleIdList></Reference><Reference><Citation>Tardif, G. , Pare, F. , Gotti, C. , Roux&#x2010;Dalvai, F. , Droit, A. , Zhai, G. , Sun, G. , Fahmi, H. , Pelletier, J. P. , &amp; Martel&#x2010;Pelletier, J. (2022). Mass spectrometry&#x2010;based proteomics identify novel serum osteoarthritis biomarkers. Arthritis Research &amp; Therapy, 24, 120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9125906</ArticleId><ArticleId IdType="pubmed">35606786</ArticleId></ArticleIdList></Reference><Reference><Citation>Travaglini, K. J. , Nabhan, A. N. , Penland, L. , Sinha, R. , Gillich, A. , Sit, R. V. , Chang, S. , Conley, S. D. , Mori, Y. , Seita, J. , Berry, G. J. , Shrager, J. B. , Metzger, R. J. , Kuo, C. S. , Neff, N. , Weissman, I. L. , Quake, S. R. , &amp; Krasnow, M. A. (2020). A molecular cell atlas of the human lung from single&#x2010;cell RNA sequencing. Nature, 587, 619&#x2013;625.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7704697</ArticleId><ArticleId IdType="pubmed">33208946</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilfong, E. M. , Lovly, C. M. , Gillaspie, E. A. , Huang, L. C. , Shyr, Y. , Casey, J. D. , Rini, B. I. , &amp; Semler, M. W. (2021). Severity of illness scores at presentation predict ICU admission and mortality in COVID&#x2010;19. The Journal of Emergency and Critical Care Medicine, 5, 7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8232354</ArticleId><ArticleId IdType="pubmed">34179689</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, Z. , Zhang, Z. , Wang, X. , Zhang, J. , Ren, C. , Li, Y. , Gao, L. , Liang, X. , Wang, P. , &amp; Ma, C. (2021). Palmitoylation of SARS&#x2010;CoV&#x2010;2 S protein is essential for viral infectivity. Signal Transduction and Targeted Therapy, 6, 231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8193602</ArticleId><ArticleId IdType="pubmed">34117209</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>